These findings underscore the importance of DNA methylation as a factor to consider in glioma treatment strategies, given that our data raise the possibility that targeting DNA methylation might influence glioma radiosensitivity in part through the regulation of UCP2 expression. This evidence concerns the gene UCP2 and central nervous system cancer.